Stem is trading at $4.41, up 6.06%, with no clear company-specific catalyst identified for its October 12 pre-market gain.
- Available search results center on earlier coverage, including Stemβs August Q2 results.
- Major U.S. indices are only modestly higher, offering no clear broader-market explanation; the reason for the move remains unclear.